Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
203 JPY | -1.93% | +1.00% | -9.38% |
Summary
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company appears to be poorly valued given its net asset value.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past twelve months, EPS forecast has been revised upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The company's enterprise value to sales, at 4.86 times its current sales, is high.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.38% | 275M | D+ | ||
+20.68% | 85.55B | C+ | ||
-29.31% | 70.07B | B- | ||
+9.23% | 29.06B | C+ | ||
-8.63% | 17.51B | B | ||
+2.14% | 17.39B | A- | ||
+0.39% | 15.38B | A- | ||
+6.47% | 13.4B | B- | ||
+68.09% | 12.87B | C- | ||
+6.43% | 12.77B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 7779 Stock
- Ratings CYBERDYNE Inc.